Save time and cost with plexWell. Contact us today!

seqWell was created to revolutionize NGS library prep to unlock the full potential of today’s DNA sequencing instruments.

Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.

In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.

Management

Dan Calvo

President and Chief Executive Officer

Joseph Mellor, PhD

Co-founder and Chief Scientific Officer

Jack T. Leonard, PhD

Co-founder and Chief Technology Officer

Tom Grant

Chief Financial Officer

Steve Smith

Chief Commercial Officer

Gavin Rush

Vice President, Research and Development

Board of Directors

Paul McEwan

Chairman of the Board

Chad Souvignier

Board Member

Mike Finney, PhD

Board Member

Rob Wilson PhD

Board Member

Amy Liao, PhD

Board Member

Dan Calvo

Board Member

Joe Mellor, PhD

Board Member

Scientific Advisors

Simone Picelli, PhD

Scientific Advisor

Jason Buenrostro, PhD

Scientific Advisor

Maryke Appel, PhD

Technical Consultant

Interested in joining our team?

We are always looking to add to our team. If you think you’d be a good fit for us, please email us at [email protected] to get in touch with someone about joining our team.

Caught in the Act: Tracking the Emergence and Divergence of SARS-CoV-2 through Statewide Testing and SequencingUPCOMING WEBINAR

Date:  March 23, 2022
Time: 11:00am (PDT),  2:00pm (EDT), 8:00pm (CEDT)

Learning Objectives

  • Understand the utility of full-genome viral sequence analysis for public health
  • Recognize how viral load impacts the ability to detect and sequence intact SARS-CoV-2
  • Identify the similarities and differences in host responses to SARS-CoV-2 depending on strain and immunologic history

Speakers

Frank A. Middleton, Ph.D.
Professor Director, SUNY Molecular Analysis CoreState University of New York (SUNY) Upstate Medical University

Joseph C. Mellor, Ph.D.
Co-founder and Chief Scientific Officer of seqWell Inc.